NCT01618903View on ClinicalTrials.gov

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

Human Volunteers

Interventions

DRUG

Levetiracetam

Levetiracetam 1.500 mg (500 mg/ 5 mL vials) administered as a 45 minutes intravenous infusion diluted in 100 mL 0.9 % saline solution in the morning of Day 1.

DRUG

Levetiracetam

Levetiracetam single oral administration of 3 tablets of 500 mg immediate release tablet.

Trial Locations (1)

Unknown

1, Shanghai